FPIN's clinical inquiries. Cardiovascular risk of combined oral contraceptive use
Fehr, A.D.; Mounsey, A.; Yates, J.E.; Flake, D.
American Family Physician 86(12): 1-2
2012
ISSN/ISBN: 1532-0650 PMID: 23316994 Document Number: 565576
Document emailed within 1 workday
Related Documents
Babineau, S.; Goodwin, C.; Walker, B. 2008: FPIN's clinical inquiries. Medications for insomnia treatment in children American Family Physician 77(3): 358-359Norris, S.; Ortiz, D.D.; Sullo, E. 2012: FPIN's Clinical Inquiries. Complementary and alternative therapies for atopic dermatitis American Family Physician 85(8): 817-823
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Costello, M.; Shrestha, B.; Eden, J.; Sjoblom, P.; Johnson, N. 2007: Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome Cochrane Database of Systematic Reviews 1: Cd005552
Vaisy, A.; Lotfinejad, S.; Zhian, F. 2014: Risk of cancer with combined oral contraceptive use among Iranian women Asian Pacific Journal of Cancer Prevention: Apjcp 15(14): 5517-5522
Malek-Khosravi, S. 2008: Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran Jpma. Journal of the Pakistan Medical Association 58(8): 473-474
Flint, P.M.; Lapane, K.L.; Barbour, M.M.; Derby, C.A.; Carleton, R.A.; Hume, A.L. 1995: Cardiovascular risk profiles of oral contraceptive users and nonusers: a population-based study Preventive Medicine 24(6): 586-590
Stuart, G.S.; Moses, A.; Corbett, A.; Phiri, G.; Kumwenda, W.; Mkandawire, N.; Chintedze, J.; Malunga, G.; Hosseinipour, M.; Cohen, M.S.; Stanczyk, F.Z.; Kashuba, A.D.M. 2011: Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi Journal of Acquired Immune Deficiency Syndromes 58(2): E40-E43
Weisberg, E.; Merki-Feld, G.S.; McGeechan, K.; Fraser, I.S. 2015: Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen Contraception 91(2): 121-126
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49
Odlind, V.; Milsom, I.; Persson, I.; Victor, A. 2002: Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstetricia et Gynecologica Scandinavica 81(6): 482-490
Davidson, B.A.; Moorman, P.G. 2014: Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer Expert Opinion on Drug Safety 13(10): 1375-1382
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Akerlund, M. 1997: Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol Acta Obstetricia et Gynecologica Scandinavica. Suppl 164: 63-65
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Chen, C.; Li, Y.; Chen, F.; Pan, H.; Shen, H.; Sun, Z.; Wu, Y.; Zhou, J.; Ba, L.; Zhao, J. 2010: Estrogen receptor beta genetic variants and combined oral contraceptive use as relates to the risk of hypertension in Chinese women Archives of Medical Research 41(8): 599-605
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
Briggs, M.H.; Briggs, M. 1977: Clinical and biochemical investigations of a variable-dose combined type oral contraceptive Current Medical Research and Opinion 5(3): 213-216
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Francis Likis 2005: Do Higher Weight And BMI Increase The Risk Of Oral Contraceptive Failure?: Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005;105:4652 Journal of Midwifery and Women's Health 50(3): 251-251